The article discusses the efficacy of aspirin compared with rivaroxaban for the prevention of venous thromboembolism (VTE) after total hip arthroplasty (THA) or total knee arthroplasty (TKA). Topics mention including receiving in-hospital prophylaxis, intention-to-treat analysis and primary efficacy outcomes of VTE.